Hadleigh Health

Helping Infants Breathe - A low-cost respiratory device for newborns and children.

The Pumani bubbleCPAP is a low-cost respiratory device for newborns and young children. The Pumani bubbleCPAP is a type of bubble Continuous Positive Airway Pressure device that provides a continuous flow of pressurized air into the patient’s airway which prevents the patient’s lungs from collapsing during exhalation. The Pumani bubbleCPAP is designed for patients who weigh between 1 and 10 kg,...
SEE ALL
The Pumani bubbleCPAP is a low-cost respiratory device for newborns and young children. The Pumani bubbleCPAP is a type of bubble Continuous Positive Airway Pressure device that provides a continuous flow of pressurized air into the patient’s airway which prevents the patient’s lungs from collapsing during exhalation. The Pumani bubbleCPAP is designed for patients who weigh between 1 and 10 kg, and it includes an oxygen blender that allows users to provide 21-100% oxygen to the patient.
SEE LESS

Stage 5: Scaling

Pumani has been distributed to all district and central hospitals in Malawi. More than 1500 are in use across 35 other countries. Today, as a NEST360° qualified technology it is being scaled further across hospitals in sub-Saharan Africa.
Registered in United Statesin United States

Focus Areas:

Health, Human Centered Design, Public-Private Partnerships and 2 MoreSEE ALL

Health, Human Centered Design, Public-Private Partnerships, Maternal Newborn and Child Health and Medical DevicesSEE LESS

$5,665,000
Funds Raised to Date
Verified Funding
?

Problem

Acute respiratory infections are the leading cause of global child mortality and respiratory conditions associated with premature birth, and they contribute to about 30 percent of neonatal death. In developed health systems, babies in respiratory distress receive ventilatory support or Bubble Continuous Airway Pressure (bCPAP). However, the typical bCPAP setup used in such settings is cost prohibitive and too resource-intensive for most health facilities in low-resource environments.

}

Solution

Pumani provides comparable therapy as more expensive commercially available bCPAP machines at a fraction of the cost. Our bCPAP system, designed for use in low-resource settings, marks a radical departure from the current use of oxygen therapy to treat Respiratory Distress Syndrome (RDS) in neonates and young infants. In addition to being easy to use, the Pumani CPAP is significantly easier to order – as it comes in one piece - and easier to maintain than other alternatives.

Target Beneficiaries

Pumani is designed for use in hospital settings to treat neonates (babies under 28 days of life) in low-resource settings who need breathing support.

Mission and Vision

Taking our innovation to the next level of scale and improving survival rates for neonates required a new approach--not just one innovation, but an entire package of technologies to support newborn care. Pumani, a partnership between Hadleigh Health and Rice360° has inspired NEST360°, a global collaborative dedicated to reducing neonatal mortality in Africa. Today, Pumani is one of the innovations in the NEST360° package providing quality newborn care to babies across Africa. (www.nest360.org)

Competitive Advantage

Pumani is designed to be effective, durable, and sustainable in low-resource settings. The characteristics that set it apart are: Effective: Provides the same level of therapeutic pressure as other commercial CPAPs. User-Friendly: Staff can be trained to use in a day; setup takes less than 5 minutes. Affordable: Costs approximately one-third of other ‘low-cost’ CPAPs on the market. Easy to Maintain: Minimal maintenance required; spare parts and repair instructions included. Durable: Shown to run continuously for years. High-Quality: Made in an ISO 13485 environment with CE marking.

Planned Goals and Milestones

NEST360° is a global collaborative developing and distributing a bundle of high-quality, affordable, easy to use, rugged products--including Pumani--and services for newborns to reduce newborn mortality in Africa. NEST is being implemented in Malawi, Kenya, Tanzania, and Nigeria and will scale to other sub-Saharan African countries. The comprehensive approach of NEST360° will serve as a proven model to provide sustainable newborn care in Africa, catalyzing change across the continent.
Projected Cumulative Lives Impacted1
New Implemented CountriesGhana, Ethiopia, Malawi, Nigeria, Kenya, Cote d'Ivoire, Uganda, Tanzania

The Team Behind the Innovation

The team responsible for developing and scaling Pumani includes leadership from three women: bioengineers Rebecca Richards-Kortum and Maria Oden of Rice 360 Institute for Global Health, and pediatrician Liz Molyneux of University of Malawi College of Medicine (COM) and Queen Elizabeth Central Hospital; and Kondwani Kawaza, neonatologist of COM and Queen Elizabeth Central Hospital and and designer and manufacturer Robert Miros of 3rd Stone Design and Hadleigh Health Technologies.

EXECUTIVE TEAM INCLUDES WOMEN

Milestone

Jun 2020
Recognition ReceivedPENDING
Jan 2020
New Product Or Service
Market Launch
Jan 2019
New Product Or Service
Used in hospitals in 35 countries

Supporting Materials

Kawaza2016-Pumani3-orientation-null.pdf
Asibon-Acta-Paediatrica-orientation-null.pdf